Bioanalysis Zone

Outsourcing: do we all have the right priorities when making a purchasing decision?

This entry is part 2 of 4 in the series Business of bioanalysis: season 2

In part 1 of this 3-part panel discussion filmed in Barcelona our panel of experts discuss the issue of outsourcing and what priorities need considering when making a purchasing decision.

Discussions include:

  • Reviewing the data from a Bioanalysis Zone outsourcing survey – 75% of pharmaceutical companies commented that the most important priority for outsourcing is cost with quality not featuring in the top three – do our experts agree?
  • What could account for the differences seen between pharma and CRO responses?
  • Do our experts agree with the findings and what improvements need to be made?

Want to download or listen on the go? Check out part 1 on Soundcloud now!

Have you enjoyed watching the panel discussion? Let us know your thoughts at n.maundrell@future-science.com or in the comments section below.

Series Navigation<< Business of bioanalysis: season twoNew regulations: what are your hopes? >>
Share: